Why is "Anti vascular endothelial growth factor therapy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-07 07:01:28
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Anti_vascular_endothelial_growth_factor_therapy entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-04-07 and was most recently seen on 2026-04-07.
Wikipedia Overview
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF therapy or medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab, antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib, sorafenib, axitinib, and pazopanib.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy - Nature
-
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe? - EMJ
-
Macular retinal detachment development associated with myopic foveoschisis - Modern Retina
-
Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: A meta-analysis of randomised trials - Wiley Online Library
-
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion - Nature
-
Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective? - EMJ
-
Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy - Nature
-
Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization - Nature
-
Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy - Nature
-
Aortic stiffness and systemic inflammation changes predict clinical response to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration - Nature
-
Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy - Nature
-
Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study - Nature
-
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.